MedPath

The effect of mefenamic acid, naproxen and placebo on periodic bleeding in wome

Phase 3
Conditions
Heavy menstrual bleeding.
Excessive and frequent menstruation with irregular cycle
Registration Number
IRCT201204241548N14
Lead Sponsor
Deputy for Research of Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
120
Inclusion Criteria

Inclusion criteria were the followings: a) being between 20 and 45 years old of age; b) normal ?results for cervical smear test; c) negative history of renal or hepatic impairment, ?thromboembolic disease, inflammatory bowel disease, peptic or intestinal ulceration, ?coagulation or fibrinolytic disorders; d) normal results for blood tests (including PT, PTT, BT, ?TSH); e) not taking any hormones and NSAIDS.?
Exclusion criteria included: a) infertility; b) overweight/obesity (BMI>25) or underweight ??(BMI<18.5); c) polycystic ovaries; d) vaginitis and/or pelvic inflammatory disease (PID); e) ?uterine polyps and/or fibroids; f) carrying IUD; g) being perimenopausal (increased serum ?FSH showed being premenopausal). ?

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Amount of menstrual bleeding. Timepoint: One month. Method of measurement: Pictorial Blood Assessment Chart ?.
Secondary Outcome Measures
NameTimeMethod
Decrease in the amount of menstrual bleeding. Timepoint: one month. Method of measurement: Pictorial Blood Assessment Chart ?.
© Copyright 2025. All Rights Reserved by MedPath